Structure–activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,407 · see citing works

Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis

Quideau, S., Deffieux, D., Douat, C., & Pouységu, L. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201000044 · Cited by 2,756 · see citing works

Genetic control of programmed cell death in the nematode C. elegans

Ellis, H. (1986) · Cell · doi:10.1016/0092-8674(86)90004-8 · Cited by 1,828 · see citing works

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized

van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,237 · see citing works

C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2

Hengartner, M. O., & Horvitz, H. R. (1994) · Cell · doi:10.1016/0092-8674(94)90506-1 · Cited by 1,167 · see citing works

Apoptosis in development

Meier, P., Finch, A. J., & Evan, G. I. (2000) · Nature · doi:10.1038/35037734 · Cited by 1,027 · see citing works

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

Konopleva, M. Y., Contractor, R., Tsao, T., Samudio, I. J., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T. B., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.006 · Cited by 1,020 · see citing works

BCL-2 family antagonists for cancer therapy

Lessène, G., Czabotar, P. E., & Colman, P. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2658 · Cited by 623 · see citing works

Prevention of Programmed Cell Death in Caenorhabditis elegans by Human bcl-2

Vaux, D. L., Weissman, I. L., & Kim, S. K. (1992) · Science · doi:10.1126/science.1470921 · Cited by 614 · see citing works

Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737

Moore, V. D. G., Brown, J. R., Certo, M. V., Love, T. M., Novina, C. D., & Letai, A. G. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28281 · Cited by 604 · see citing works

Mcl‐1; the molecular regulation of protein function

Thomas, L. W., Lam, C. W., & Edwards, S. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.061 · Cited by 540 · see citing works

BH3 Profiling Identifies Three Distinct Classes of Apoptotic Blocks to Predict Response to ABT-737 and Conventional Chemotherapeutic Agents

Deng, J., Carlson, N. E., Takeyama, K., Cin, P. D., Shipp, M. A., & Letai, A. G. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.001 · Cited by 509 · see citing works

Apoptosis-targeted therapies for cancer

Reed, J. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00241-6 · Cited by 502 · see citing works

4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer

Brough, P. A., Aherne, W., Barril, X., Borgognoni, J., Boxall, K. J., Cansfield, J. E., Cheung, K.-M. J., Collins, I., Davies, N. G. M., Drysdale, M. J., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701018h · Cited by 449 · see citing works

Mechanisms of apoptosis avoidance in cancer

Reed, J. C. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199901000-00014 · Cited by 371 · see citing works

The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members

Verdine, G. L., & Walensky, L. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2184 · Cited by 362 · see citing works

Bcl-2 inhibitors: small molecules with a big impact on cancer therapy

Vogler, M., Dinsdale, D. D., Dyer, M. J. S., & Cohen, G. M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.137 · Cited by 359 · see citing works

Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis

Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan‐Cadars, M., Jockers, R., Barberis, C., & Bouvier, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0222 · Cited by 323 · see citing works

Structure-Based Design of Potent Small-Molecule Inhibitors of Anti-Apoptotic Bcl-2 Proteins

Wang, G., Nikolovska‐Coleska, Z., Yang, C., Wang, R., Tang, G., Guo, J., Shangary, S. K., Qiu, S., Gao, W., Yang, D., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060460o · Cited by 293 · see citing works

Mimicking the BH3 domain to kill cancer cells

Chonghaile, T. N., & Letai, A. G. (2008) · Oncogene · doi:10.1038/onc.2009.52 · Cited by 268 · see citing works

BCL-2 in the crosshairs: tipping the balance of life and death

Walensky, L. D. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401992 · Cited by 245 · see citing works

Polyphenols and cancer cell growth

Kampa, M., Nifli, A., Notas, G., & Castanas, E. (2007) · Springer eBooks · doi:10.1007/112_2006_0702 · Cited by 193 · see citing works

Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer

Shore, G. C., & Warr, M. R. (2008) · Current Molecular Medicine · doi:10.2174/156652408783769580 · Cited by 193 · see citing works

BH3 mimetics to improve cancer therapy; mechanisms and examples

Zhang, L., Ming, L., & Yu, J. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.08.002 · Cited by 139 · see citing works

The Small Organic Compound HA14-1 Prevents Bcl-2 Interaction with Bax to Sensitize Malignant Glioma Cells to Induction of Cell Death

Manero, F., Gautier, F., Gallenne, T., Cauquil, N., Gree, D. M., Cartron, P., Geneste, O., Gree, R. L., Vallette, F. M., & Juin, P. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2097 · Cited by 134 · see citing works

Pre-Enucleation Chemotherapy for Eyes Severely Affected by Retinoblastoma Masks Risk of Tumor Extension and Increases Death From Metastasis

Zhao, J., Dimaras, H., Massey, C., Xu, X., Huang, D., Li, B., Chan, H. S. L., & Gallie, B. L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5332 · Cited by 120 · see citing works

Non‐peptidic small molecule inhibitors against Bcl‐2 for cancer therapy

Azmi, A. S., & Mohammad, R. M. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21567 · Cited by 119 · see citing works

Drugs targeting Bcl-2 family members as an emerging strategy in cancer

Leber, B. F., Geng, F., Kale, J., & Andrews, D. W. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001572 · Cited by 88 · see citing works

Bcl-2 family members as molecular targets in cancer therapy

Marzo, I., & Naval, J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.009 · Cited by 87 · see citing works

Aminoglycoside suppression of nonsense mutations in severe hemophilia

James, P. D., Raut, S., Rivard, G., Poon, M., Warner, M., McKenna, S., Leggo, J., & Lillicrap, D. (2005) · Blood · doi:10.1182/blood-2005-03-1307 · Cited by 85 · see citing works

Expanding Circle of Inhibition: Small-Molecule Inhibitors of Bcl-2 as Anticancer Cell and Antiangiogenic Agents

Zeitlin, B. D., Zeitlin, I. J., & Nor, J. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7693 · Cited by 81 · see citing works

Acylpyrogallols as Inhibitors of Antiapoptotic Bcl-2 Proteins

Tang, G., Nikolovska‐Coleska, Z., Qiu, S., Yang, C., Guo, J., & Wang, S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701358v · Cited by 81 · see citing works

Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol

Amblard, F., Govindarajan, B., Lefkove, B., Rapp, K. L., Detorio, M., Arbiser, J. L., & Schinazi, R. F. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.06.024 · Cited by 68 · see citing works

Shooting at survivors: Bcl-2 family members as drug targets for cancer

Juin, P. P., Geneste, O., Raimbaud, E., & Hickman, J. A. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.10.010 · Cited by 64 · see citing works

Pyrogallol-Based Molecules as Potent Inhibitors of the Antiapoptotic Bcl-2 Proteins

Tang, G., Yang, C., Nikolovska‐Coleska, Z., Guo, J., Qiu, S., Wang, R., Gao, W., Wang, G., Stuckey, J. A., Krajewski, K., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061400l · Cited by 48 · see citing works

The synthesis of new, selected analogues of the pro-apoptotic and anticancer molecule HA 14-1

Gree, D. M., Vorin, S., Manthati, V. L., Caïjo, F., Viault, G., Manero, F., Juin, P. P., & Gree, R. L. (2008) · Tetrahedron Letters · doi:10.1016/j.tetlet.2008.03.070 · Cited by 46 · see citing works

Insulin Breast Cancer Connection: Confirmatory Data Set the Stage for Better Care

DeCensi, A., & Gennari, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.3022 · Cited by 45 · see citing works

HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells

Oliver, L., Mahé, B., Gree, R. L., Vallette, F. M., & Juin, P. P. (2007) · Leukemia Research · doi:10.1016/j.leukres.2006.11.010 · Cited by 37 · see citing works

Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties

Bertini, S., Calderone, V., Carboni, I., Maffei, R., Martelli, A., Martinelli, A., Minutolo, F., Rajabi, M., Testai, L., Tuccinardi, T., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.07.059 · Cited by 36 · see citing works

Bax Activation by Engagement with, Then Release from, the BH3 Binding Site of Bcl-x L

Gautier, F., Guillemin, Y., Cartron, P., Gallenne, T., Cauquil, N., Diguarher, T. L., Casara, P., Vallette, F. M., Manon, S., Hickman, J. A., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00161-10 · Cited by 35 · see citing works

The first synthesis of 2-amino-1,4-dihydroquinolines

Viault, G., Gree, D. M., Roisnel, T., Chandrasekhar, S., & Gree, R. L. (2009) · Tetrahedron · doi:10.1016/j.tet.2009.10.018 · Cited by 18 · see citing works

Miscellaneous cancers associated with AIDS

Cohen, P. (1989) · Current Opinion in Oncology · doi:10.1097/00001622-198910000-00014 · Cited by 9 · see citing works

Modulators of Protein–Protein Interactions

Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497 · see citing works

Bcl-xL controls a switch between cell death modes during mitotic arrest

Bah, N. K., Maillet, L., Ryan, J. A., Dubreil, S., Gautier, F., Letai, A. G., Juin, P. P., & Barillé‐Nion, S. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.251 · Cited by 61 · see citing works

First Evidence That Oligopyridines, α-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-x L -Targeting Strategies

Gloaguen, C., Voisin‐Chiret, A. S., Santos, J. S. O., Fogha, J., Gautier, F., Giorgi, M. D., Burzicki, G., Perato, S., Pétigny-Lechartier, C., Simonin, K., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm500672y · Cited by 53 · see citing works

Protein–Protein Interactions as Drug Targets

Skwarczynska, M., & Ottmann, C. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.138 · Cited by 50 · see citing works

Plant Polyphenols

Valavanidis, A., & Vlachogianni, T. (2013) · Studies in natural products chemistry · doi:10.1016/b978-0-444-62615-8.00008-4 · Cited by 47 · see citing works

Toward chelerythrine optimization: Analogues designed by molecular simplification exhibit selective growth inhibition in non-small-cell lung cancer cells

Yang, R., Tavares, M. T., Teixeira, S. F., Azevedo, R., Pietro, D. C., Fernandes, T. B., Ferreira, A. K., Trossini, G. H. G., Barbuto, J. A. M., & Parise‐Filho, R. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.065 · Cited by 15 · see citing works

Molecular diversity of phenothiazines: design and synthesis of phenothiazine–dithiocarbamate hybrids as potential cell cycle blockers

Fu, D., Zhao, R.-H., Li, J., Yang, J., Mao, R.-W., Wu, B., Li, P., Zi, X., Zhang, Q., Cai, H., et al. (2017) · Molecular Diversity · doi:10.1007/s11030-017-9773-4 · Cited by 13 · see citing works

Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cells

Vo, D. D., Gautier, F., Barillé‐Nion, S., Juin, P. P., Levoin, N., & Gree, R. L. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.02.035 · Cited by 9 · see citing works

A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors

Levoin, N., Vo, D. D., Gautier, F., Barillé‐Nion, S., Juin, P. P., Tasseau, O., & Gree, R. L. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.02.060 · Cited by 9 · see citing works

Synthesis of new mixed phenol/heterocyclic derivatives and studies of their activity as inhibitors of Bax/Bcl-xL interaction

Vo, D. D., Gautier, F., Barillé‐Nion, S., Juin, P. P., Levoin, N., & Gree, R. L. (2013) · Tetrahedron · doi:10.1016/j.tet.2013.11.060 · Cited by 7 · see citing works

Targeting PUMA/Bcl-xL interaction by new specific compounds to unleash apoptotic process in cancer cells

Murthy, A. V. R., Narendar, V., Kumar, N. S., Aparna, P., Bhavani, A. K. D., Gautier, F., Barillé‐Nion, S., Juin, P. P., Mosset, P., Gree, R. L., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.069 · Cited by 5 · see citing works

Structural revision of the Mcl-1 inhibitor MIM1: synthesis and biological studies on ovarian cancer cells with evaluation of designed analogues

Paysant, H., Hedir, S., Justaud, F., Weiswald, L., Dine, A. N. E., Soulieman, A., Hachem, A., Elie, N., Brotin, É., Denoyelle, C., et al. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob01521d · Cited by 4 · see citing works

Conception, synthèse et évaluation biologique d’inhibiteurs des protéines anti-apoptotiques de la famille Bcl-2

Samra, A. A. (2017) · doi:10.70675/b102c54fzd500z453ez82dfzc60e29a02c7b

Preparation of new fluorinated analogs of GABA and development of new inhibitors of antiapoptotic proteins with anticancer activity

Soulieman, A. (2021) · theses.fr (ABES) · doi:10.70675/3bd23494z6c0az4dc1zaa62zfc963037b880

BindingDB Entry 50045529: A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors.

BindingDB (2016) · UC San Diego · doi:10.7270/q2f191d6

Synthesis of new mixed phenol/heterocyclic derivatives and studies of their activity as inhibitors of Bax/Bcl-xL interaction

Vo, D. D., Gautier, F., Barillé‐Nion, S., Juin, P. P., Levoin, N., & Gree, R. L. (2013) · Tetrahedron · doi:10.1016/j.tet.2013.11.060 · Cited by 7 · see citing works

ChemInform Abstract: Synthesis of New Mixed Phenol/Heterocyclic Derivatives and Studies of Their Activity as Inhibitors of Bax/Bcl‐xL Interaction.

Vo, D. D., Gautier, F., Barillé‐Nion, S., Juin, P. P., Levoin, N., & Gree, R. L. (2014) · ChemInform · doi:10.1002/chin.201428081

Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cells

Vo, D. D., Gautier, F., Barillé‐Nion, S., Juin, P. P., Levoin, N., & Gree, R. L. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.02.035 · Cited by 9 · see citing works

Design, Synthesis, and Evaluation of Phenylpyrrole Derivatives as Small-Molecule Activators of BAX

Cai, W., Li, Z., Zhao, M., Gu, Y., Qiu, C., Zhou, M., Deng, W., Zhou, L., Li, Y., & Wang, R. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02670 · Cited by 2 · see citing works

Preliminary Studies on the Activity of Mixed Polyphenol-Heterocyclic Systems Against B16-F10 Melanoma Cancer Cells

Vo, D. D., Rouaud, I., Dévéhat, F. L., Gautier, F., Barillé‐Nion, S., Juin, P. P., Levoin, N., Boustié, J., & Gree, R. L. (2016) · Medicinal Chemistry · doi:10.2174/1573406412666160129104603 · Cited by 5 · see citing works